| Literature DB >> 22733406 |
Arkadiusz Derkacz1, Marcin Protasiewicz, Rafał Poręba, Adrian Doroszko, Ryszard Andrzejak.
Abstract
The angioplasty procedure is associated with a release of numerous factors triggering the local inflammatory reaction in vascular wall and leading thus to the restenosis. In this study, we hypothesize that the low-energy laser irradiation may exert beneficial effect by limiting this process. A group of 101 subjects (75 men and 26 women, mean age: 59.1 ± 10.3) treated with percutaneous coronary intervention (PCI), were recruited to this study. While 52 patients (40 men and 12 women) were subjected to the intravascular low-energy laser irradiation (λ=808 nm) of dilated lesion during the PCI, the remaining patients (35 men and 14 women) constituted the control group. The levels of interleukin 1β, 6 and 10 (IL 1β, IL 6 and IL 10) were measured immediately before the procedure, and then at the 6th, 12th hour as well as after 1 month following the PCI. Significantly lower levels of IL 1β and IL 6 in the irradiated group during each analysis after the procedure were observed. Moreover, significantly lower IL 10 level in irradiated group within 6 and 12 hours after PCI was observed. Irradiation of the lesion with low-energy laser radiation during the PCI procedure results in a decrease in the levels of pro-inflammatory IL 1β and IL 6 as well as in an increase in the levels of anti-inflammatory IL 10, which may result in decreased risk for restenosis.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22733406 PMCID: PMC3637891 DOI: 10.1007/s10103-012-1142-z
Source DB: PubMed Journal: Lasers Med Sci ISSN: 0268-8921 Impact factor: 3.161
Demographic, clinical and procedural characteristics of analyzed groups
| Laser-treated group | Control group |
| |
|---|---|---|---|
| Total number of patients | 52 | 49 | NS |
| Women | 12 | 14 | NS |
| Men | 40 | 35 | NS |
| Age for the total group [years] | 57.3 ± 11.3 | 60.7 ± 9.5 | NS |
| Age of women [years] | 64.1 ± 12.1 | 63.5 ± 9.4 | NS |
| Age of men [years] | 55.2 ± 10.2 | 57.9 ± 9.7 | NS |
| Coronary artery disease | |||
| CCS I | 12 | 6 | NS |
| CCS II | 21 | 22 | NS |
| CCS III | 12 | 14 | NS |
| CCS IV | 7 | 7 | NS |
| Arterial hypertension | 24 | 30 | NS |
| Tobacco smoking | 34 | 31 | NS |
| Total cholesterol [mg/dl] | 199.9 ± 52.0 | 198.3 ± 45.4 | NS |
| LDL cholesterol [mg/dl] | 123.4 ± 43.5 | 123.7 ± 38.6 | NS |
| HDL cholesterol [mg/dl] | 46.4 ± 9.7 | 42.7 ± 8.1 | NS |
| Triglycerides [mg/dl] | 151.5 ± 87.2 | 156.4 ± 83.6 | NS |
| Dilated artery | |||
| LAD | 29 | 23 | NS |
| RCA | 12 | 13 | NS |
| Cx/OM | 11 | 13 | NS |
| Lesion supplied with balloons | |||
| LAD | 7 | 3 | NS |
| RCA | 4 | 6 | NS |
| Cx/OM | 3 | 6 | NS |
| Lesion supplied with stents | |||
| LAD | 22 | 20 | NS |
| RCA | 9 | 7 | NS |
| Cx/OM | 7 | 7 | NS |
| Reference diameter of dilated artery [mm] | 3.20 ± 0.44 | 3.11 ± 0.43 | NS |
| Lesion length [mm] | 13.6 ± 5.0 | 12.0 ± 3.1 | NS |
| MLD before angioblasty | 0.83 ± 0.45 | 0.85 ± 0.42 | NS |
| MLD after angioplasty | 2.71 ± 0.38 | 2.52 ± 0.37 | NS |
| Myocardial infarction in the past, totala) | 32 | 29 | NS |
| -/- in region supplied by dilated artery | 29 | 26 | NS |
| -/- in another region | 6 | 3 | NS |
CCS Canadian Cardiovascular Society, MLD minimal lumen diameter
aNumber of subjects who experienced myocardial infarction in the past (in group I, every of three persons experienced two infarctions; in group II, one person experienced two infarctions). Evaluation whether infarction developed in the area supplied by the dilated artery, in some cases, may be only tentative
Fig. 1Serum interleukin 1β levels [pg/ml] in analysed groups at particular steps of the study protocol
Fig. 2Serum interleukin 6 levels [pg/ml] in analysed groups at particular steps of the study protocol
Fig. 3Serum interleukin 10 levels [pg/ml] in analysed groups at particular steps of the study protocol